CORT 63.54 (-2.38%)
US2183521028BiotechnologyBiotechnology

Corcept Therapeutics (CORT) Stock Highlights

63.54 | -2.38%
2025-02-22 01:57:03
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Statistics

Range Today
63.19 66.48
Volume Today 1.18M
Range 1 Year
20.84 75
Volume 1 Year 244.39M
Range 3 Year
17.19 75
Volume 3 Year 664.04M
Range 10 Year
3.22 75
Volume 10 Year 2.38B

Highlights

Market Capitalization 6.66B (mid)
Floating Shares 86.18M
Current Price 63.54
Price To Earnings 52.3
Price To Revenue 10.26
Price To Book 10.41
Earnings Per Share 1.26
Payout Ratio 0%

Performance

Latest -2.38%
1 Month +12.8%
3 Months +13.14%
6 Months +84.55%
1 Year +183.91%
3 Years +185.7%
5 Years +354.51%
10 Years +1796.72%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.